NO20083422L - Antismittelosning omfattende en forbindelse av pyrido(3,2,1-IJ)- benzoksadizantype - Google Patents

Antismittelosning omfattende en forbindelse av pyrido(3,2,1-IJ)- benzoksadizantype

Info

Publication number
NO20083422L
NO20083422L NO20083422A NO20083422A NO20083422L NO 20083422 L NO20083422 L NO 20083422L NO 20083422 A NO20083422 A NO 20083422A NO 20083422 A NO20083422 A NO 20083422A NO 20083422 L NO20083422 L NO 20083422L
Authority
NO
Norway
Prior art keywords
gen
pyrido
substituted
optionally
benzoxadizane
Prior art date
Application number
NO20083422A
Other languages
English (en)
Inventor
Marinette Moreau
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of NO20083422L publication Critical patent/NO20083422L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår en anti-infektiv løsning som innbefatter minst en forbindelse av pyrido(3,2,1 -ij)-benzoksadiazintypen som korresponderer til formel (I) eller minst av dens farmasøytisk akseptable salter og minst et solubiliseringsmiddel, i en farmasøytisk akseptabel bærer.
NO20083422A 2006-01-24 2008-08-05 Antismittelosning omfattende en forbindelse av pyrido(3,2,1-IJ)- benzoksadizantype NO20083422L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0650246A FR2896416B1 (fr) 2006-01-24 2006-01-24 Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
PCT/FR2007/050682 WO2007085760A2 (fr) 2006-01-24 2007-01-24 Solution anti-infectieuse comprenant un compose de type pyrido(3,2,1-ij)-benzoxadiazine

Publications (1)

Publication Number Publication Date
NO20083422L true NO20083422L (no) 2008-10-08

Family

ID=36748355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083422A NO20083422L (no) 2006-01-24 2008-08-05 Antismittelosning omfattende en forbindelse av pyrido(3,2,1-IJ)- benzoksadizantype

Country Status (25)

Country Link
US (1) US8796265B2 (no)
EP (2) EP1976561B1 (no)
JP (1) JP5221383B2 (no)
CN (1) CN101405032B (no)
AT (1) ATE520418T1 (no)
AU (1) AU2007209245B2 (no)
BR (1) BRPI0706956B1 (no)
CA (1) CA2637941C (no)
CY (1) CY1112481T1 (no)
DK (1) DK1976561T3 (no)
EA (1) EA016154B1 (no)
ES (2) ES2813856T3 (no)
FR (1) FR2896416B1 (no)
HK (1) HK1128883A1 (no)
HU (1) HUE050643T2 (no)
IL (1) IL192935A (no)
MX (1) MX2008009470A (no)
NO (1) NO20083422L (no)
NZ (1) NZ570332A (no)
PL (2) PL2438929T3 (no)
PT (2) PT1976561E (no)
SI (2) SI2438929T1 (no)
UA (1) UA94086C2 (no)
WO (1) WO2007085760A2 (no)
ZA (1) ZA200806369B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EP2332916A3 (en) 2009-11-19 2011-08-03 Krka Tovarna Zdravil, D.D., Novo Mesto A process for a preparation of marbofloxacin and intermediate thereof
CN103271875A (zh) * 2013-07-01 2013-09-04 浙江华尔成生物药业股份有限公司 一种注射用麻保沙星冻干粉及其制备方法与应用
US10519409B2 (en) * 2014-12-31 2019-12-31 Ge Healthcare Bio-Sciences Corp. Shaft-mounted fluid transfer assembly for a disposable bioreactor
US10440147B2 (en) 2015-11-24 2019-10-08 William Edward Woodcock, IV Quality-of-service management for domain name service
US20170239250A1 (en) 2016-02-19 2017-08-24 Eagle Pharmaceuticals, Inc. Pemetrexed formulations
CN107445977B (zh) * 2017-07-13 2019-08-09 江西傲新生物科技有限公司 一种水溶性马波沙星及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3788177D1 (de) * 1986-09-12 1993-12-23 Hoffmann La Roche Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
DE19519822A1 (de) * 1995-05-31 1996-12-05 Bayer Ag Neue antibakterielle Mittel
PL186795B1 (pl) 1995-12-21 2004-02-27 Pfizer Preparat farmaceutyczny zawierający danofloksacynę
GB9600894D0 (en) * 1996-01-17 1996-03-20 Pfizer Novel compound
GB9600886D0 (en) * 1996-01-17 1996-03-20 Pfizer Novel compound
GB9601356D0 (en) * 1996-01-24 1996-03-27 Pfizer Novel compound
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
CA2546195A1 (en) * 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants

Also Published As

Publication number Publication date
PT2438929T (pt) 2020-09-01
WO2007085760A2 (fr) 2007-08-02
EP2438929A3 (fr) 2012-07-18
BRPI0706956B1 (pt) 2019-08-13
EP2438929A2 (fr) 2012-04-11
WO2007085760A3 (fr) 2007-10-11
SI2438929T1 (sl) 2020-10-30
DK1976561T3 (da) 2011-12-05
IL192935A0 (en) 2009-02-11
ES2813856T3 (es) 2021-03-25
BRPI0706956A2 (pt) 2011-04-12
CN101405032A (zh) 2009-04-08
EA016154B1 (ru) 2012-02-28
EP2438929B1 (fr) 2020-06-10
ATE520418T1 (de) 2011-09-15
US8796265B2 (en) 2014-08-05
EP1976561B1 (fr) 2011-08-17
UA94086C2 (ru) 2011-04-11
HUE050643T2 (hu) 2020-12-28
FR2896416B1 (fr) 2010-08-13
FR2896416A1 (fr) 2007-07-27
PL1976561T3 (pl) 2012-01-31
CA2637941A1 (fr) 2007-08-02
PT1976561E (pt) 2011-11-17
AU2007209245A1 (en) 2007-08-02
PL2438929T3 (pl) 2020-12-14
ZA200806369B (en) 2009-08-26
NZ570332A (en) 2010-09-30
JP2009523840A (ja) 2009-06-25
HK1128883A1 (en) 2009-11-13
CY1112481T1 (el) 2015-12-09
EA200801733A1 (ru) 2008-12-30
AU2007209245B2 (en) 2013-09-12
JP5221383B2 (ja) 2013-06-26
US20100280022A1 (en) 2010-11-04
CN101405032B (zh) 2013-01-16
EP1976561A2 (fr) 2008-10-08
SI1976561T1 (sl) 2011-12-30
MX2008009470A (es) 2008-09-23
CA2637941C (fr) 2014-01-21
ES2371941T3 (es) 2012-01-11
IL192935A (en) 2014-02-27

Similar Documents

Publication Publication Date Title
CY1112481T1 (el) Αντι-μολυσματικο διαλυμα που περιλαμβανει μια ενωση του τυπου πυριδο(3,2,1-ij)-βενζοξαδιαζινης
MX2007010072A (es) Derivados de piperidina antibacterianos.
MY148688A (en) 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors
TW200637839A (en) 1-thio-d-glucitol derivatives
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
MY149622A (en) Pyrazoles as 11-beta-hsd-1
MX2009005603A (es) Compuestos de urea policiclicos antibacterianos.
TW200502230A (en) Dual nk1/nk3 derivatives
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
TNSN08407A1 (en) Organic compounds
SG159388A1 (en) Antibacterial agents
WO2008154642A3 (en) Antibacterial agents
TW200833663A (en) Therapeutic agents
MY162940A (en) Quinoline derivative-containing pharmaceutical composition
TW200643013A (en) Pyrazoles
MX2009012390A (es) Uso de compuestos de 4-(pirrolidin-1-il)quinolina para exterminar microorganismos clinicamente latentes.
DE602006021539D1 (en) Morpholine als 5ht2c-agonisten
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.
UA96304C2 (en) 2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2009016081A3 (en) Benzoind0l-2-one derivatives for use in therapy
IL195837A0 (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]
MX2009012124A (es) Compuestos terapeuticos estereoisomeros de propofol.
MXPA05013717A (es) Derivados de acido 2-etoxi-2-fenilpropionico para el tratamiento de trastornos de lipido.
UA94735C2 (ru) Производные пурина, предназначенные для применения в качестве агонистов аденозинового рецептора а2а

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application